NTRA publication cites strong clinical validation for Signatera MRD in lymphoma
TradeXchange Newsdesk says NTRA published findings supporting Signatera for MRD assessment in lymphoma.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
TradeXchange Newsdesk says NTRA published findings supporting Signatera for MRD assessment in lymphoma.